Researchers have found that high doses of intravenous vitamin C may have potential benefits in cancer treatment, challenging previous beliefs that oral vitamin C had no effect. While Linus Pauling’s claims about vitamin C as a cancer fighter were largely dismissed after studies showed no benefit from pills, new evidence suggests that administering vitamin C directly into the bloodstream can achieve much higher concentrations. These elevated levels can damage cancer cells while sparing healthy ones, acting more like a chemotherapy agent than a simple vitamin supplement.

This discovery is significant for those interested in improving health outcomes, particularly for individuals battling hard-to-treat cancers like ovarian, pancreatic, or brain tumors. Early studies indicate that patients receiving vitamin C infusions alongside chemotherapy often report improved quality of life, experiencing less fatigue, pain, and nausea. While the effects on survival rates remain inconclusive, the potential for enhanced well-being during treatment is noteworthy.

However, it’s important to approach this information with caution. Current research is still in the early stages, with small trials showing mixed results. Although some patients tolerate high-dose vitamin C infusions well, there are risks, especially for those with certain health conditions. No large-scale, definitive trials have confirmed that intravenous vitamin C prolongs life for most cancer patients, so it should not replace standard treatments. Instead, it should be considered experimental and only administered in clinical settings where it can be monitored closely.

Source: Science Daily